Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
22
LICN Quote, Financials, Valuation and Earnings
Last price:
$3.00
Seasonality move
:
-16.84%
Day range:
$3.01 - $3.04
52-week range:
$2.57 - $18.00
Dividend yield:
0%
P/E ratio:
0.70x
P/S ratio:
0.02x
P/B ratio:
0.21x
Volume:
920
Avg. volume:
6.6K
1-year change:
-78.66%
Market cap:
$2.3M
Revenue:
$41.5M
EPS (TTM):
--
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Lichen International Ltd. has -- downside to fair value with a price target of -- per share.
LICN vs. S&P 500
-
Over the past 5 trading days, Lichen International Ltd. has underperformed the S&P 500 by -1.68% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Lichen International Ltd. does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Lichen International Ltd. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Lichen International Ltd. reported revenues of --.
Earnings Growth
-
Lichen International Ltd. has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Lichen International Ltd. reported earnings per share of --.
Enterprise value:
-2.3M
EV / Invested capital:
--
Price / LTM sales:
0.02x
EV / EBIT:
-2.86x
EV / Revenue:
-0.06x
PEG ratio (5yr expected):
0.01x
EV / Free cash flow:
0.21x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
-2.86x
Gross Profit (TTM):
$19M
Return On Assets:
11.96%
Net Income Margin (TTM):
-42.69%
Return On Equity:
12.6%
Return On Invested Capital:
12.6%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2022-12-31 | 2023-12-31 | |
| Income Statement | ||||||
| Revenue | $34.3M | $33.8M | $39.8M | -- | -- | |
| Gross Profit | $20.5M | $20.2M | $24.3M | -- | -- | |
| Operating Income | $11.3M | $10.6M | $12.3M | -- | -- | |
| EBITDA | $13.7M | $13.3M | $12.3M | -- | -- | |
| Diluted EPS | $63.86 | $54.39 | $63.96 | -- | -- | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | $24.6M | $29.8M | $49.2M | -- | |
| Total Assets | -- | $44.5M | $56.2M | $72.6M | -- | |
| Current Liabilities | -- | $5.4M | $2.8M | $2.8M | -- | |
| Total Liabilities | -- | $5.4M | $2.9M | $2.8M | -- | |
| Total Equity | -- | $39.1M | $53.3M | $69.8M | -- | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2014-12-31 | 2015-12-31 | 2016-12-31 | 2015-12-31 | 2016-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | $3M | |
| Cash From Investing | -- | -- | -- | -- | -$2.4M | |
| Cash From Financing | -- | -- | -- | -- | -$2.7M | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
LICN
Sector
Market Cap
$2.3M
$477M
Price % of 52-Week High
16.84%
84.06%
Dividend Yield
0%
0%
Shareholder Yield
-344.48%
1.68%
1-Year Price Total Return
-78.66%
--
Beta (5-Year)
--
0.541
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$3.03
200-day SMA
Sell
Level
$4.00
Bollinger Bands (100)
Sell
Level
2.89 - 3.99
Chaikin Money Flow
Buy
Level
10.7K
20-day SMA
Sell
Level
$3.03
Relative Strength Index (RSI14)
Sell
Level
48.83
ADX Line
Sell
Level
12.81
Williams %R
Neutral
Level
-37.5379
50-day SMA
Sell
Level
$3.07
MACD (12, 26)
Buy
Level
0.68
25-day Aroon Oscillator
Sell
Level
-28
On Balance Volume
Neutral
Level
32.6K
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.6874)
Buy
CA Score
(Annual)
Level (1.4315)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (1)
Buy
Ohlson Score
Level (-2)
Sell
Piotroski F Score
(Annual)
Level (3)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Lichen International Ltd. engages in providing financial and taxation solutions. It also offers educational support, and software and maintenance services. The company was founded by Li Ya on April 13, 2016 and is headquartered in Jinjiang, China.
Stock Forecast FAQ
In the current month, LICN has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The LICN average analyst price target in the past 3 months is --.
-
Where Will Lichen International Ltd. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Lichen International Ltd. share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Lichen International Ltd.?
Analysts are divided on their view about Lichen International Ltd. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Lichen International Ltd. is a Sell and believe this share price will rise from its current level to --.
-
What Is Lichen International Ltd.'s Price Target?
The price target for Lichen International Ltd. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is LICN A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Lichen International Ltd. is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of LICN?
You can purchase shares of Lichen International Ltd. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Lichen International Ltd. shares.
-
What Is The Lichen International Ltd. Share Price Today?
Lichen International Ltd. was last trading at $3.00 per share. This represents the most recent stock quote for Lichen International Ltd.. Yesterday, Lichen International Ltd. closed at $3.03 per share.
-
How To Buy Lichen International Ltd. Stock Online?
In order to purchase Lichen International Ltd. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get LICN Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
LICN
Sector
P/E ratio
0.70x
20.49x
PEG ratio
0.01x
0.18x
P/B ratio
0.21x
1.83x
Price / LTM sales
0.02x
0.90x
Growth Metrics
LICN
Sector
Revenue growth
--
4.73%
Earnings growth
--
1.78%
Revenue (5-year growth)
5.59%
4.81%
Earnings forecast
--
$0.33
Profitability
LICN
Sector
Profitability FY 2024
$23.6M
$222.3M
Return on invested capital
12.6%
4.52%
Return on assets
11.96%
3.1%
Return on equity
12.6%
7.98%
Earnings Date
Last Earnings Date
Feb
22
Next Earnings Date
Feb
22
Estimated Next Earnings Date
May
24
Balance Sheet
LICN
Sector
Total cash
$34.2M
$134.4M
Short term investments
--
$31.1M
Total assets
$79.8M
$1.3B
Long term debt
--
$39.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Sell
50
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 29x
Alerts
Buy
77
RNG alert for Feb 21
RingCentral, Inc. [RNG] is up 34.37% over the past day.
Sell
9
FROG alert for Feb 21
JFrog Ltd. [FROG] is down 24.98% over the past day.
Buy
72
SNSE alert for Feb 21
Sensei Biotherapeutics, Inc. [SNSE] is up 23.81% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
